supp.fit

Activated Charcoal: study protocols

79 study groups say how much Activated Charcoal participants took a day. These are the doses the studies gave. They are not a recommendation.

Activated Charcoal: what the research found →

Dose per serving from products

233 products in our catalogue print how much Activated Charcoal a serving holds.

Most common: 500 mg to 1 g, 43% of 233 products.

Dose per servingProducts
25 mg or less
1
25 mg to 50 mg
16
50 mg to 100 mg
19
100 mg to 250 mg
32
250 mg to 500 mg
42
500 mg to 1 g
100
1 g to 2.5 g
23

Dose per serving from research

79 study groups in 45 studies say how much Activated Charcoal participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 g to 25 g, 41% of 79 study groups.

Daily doseStudy groups
2.5 g or less
4
2.5 g to 5 g
2
5 g to 10 g
16
10 g to 25 g
32
25 g to 50 g
12
50 g to 100 g
9
100 g to 250 g
2
over 250 g
2

Commonly used together

5 of 79 study groups took Activated Charcoal with something else, but nothing that 3 or more different studies gave.

79 study groups

Study
Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial
2003 · multiple-dose activated charcoal · Patients with yellow-oleander poisoning
200 g3 days201
Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease
2019 · OAC group (phase 1) · Adults with stage 3–4 chronic kidney disease and normal serum calcium, phosphorus, and PTH levels
1.8 g1 year49
Activated charcoal to prevent irinotecan-induced diarrhea in children
2008 · experimental group · children receiving irinotecan as part of chemotherapy; ages and diagnoses not specified
750 mg—10
Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial
2017 · SC (simethicone and activated charcoal) · Adults over 18 with flatus incontinence and a positive glucose breath test for small intestinal bacterial overgrowth
420 mg10 days8
Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial
2007 · SDAC · Patients admitted to hospitals in Sri Lanka after acute self-poisoning
50 g1 day559
Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial
2007 · MDAC · Patients admitted to hospitals in Sri Lanka after acute self-poisoning
300 g1 day544
Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial
1999 · CharcoAid G (CA) · Alert adults with known or suspected potentially toxic ingestions requiring activated charcoal
60 g1 day31
Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial
1999 · LiquiChar (LC) · Alert adults with known or suspected potentially toxic ingestions requiring activated charcoal
60 g1 day29
Adverse effects of superactivated charcoal administered to healthy volunteers
2002 · superactivated charcoal group · healthy adult volunteers
75 g1 day24
Oral activated charcoal in patients with uremic pruritus
1995 · activated powdered charcoal · 23 chronic uremic patients on maintenance hemodialysis with severe pruritus
6 g—23
A STUDY ON THE HAEMODYNAMIC INTERACTIONS BETWEEN ACTIVATED CHARCOAL AND PROPRANOLOL/ATENOLOL IN NORMAL HUMAN SUBJECTS
1999 · activated charcoal with propranolol · 12 normal adult male volunteers
15 g1 day—
A STUDY ON THE HAEMODYNAMIC INTERACTIONS BETWEEN ACTIVATED CHARCOAL AND PROPRANOLOL/ATENOLOL IN NORMAL HUMAN SUBJECTS
1999 · activated charcoal with atenolol · 12 normal adult male volunteers
15 g1 day—
Effects of Increased Blood Flow Rate and Oral Activated Charcoal on the Severity of Uremic Pruritus: A Randomized Crossover Clinical Trial
2023 · Daily administration of a charcoal suspension · Hemodialysis patients with uremic pruritus
6 g2 weeks—
Effects of Increased Blood Flow Rate and Oral Activated Charcoal on the Severity of Uremic Pruritus: A Randomized Crossover Clinical Trial
2023 · Concurrent use of increased pumping speed and oral administration of the charcoal suspension · Hemodialysis patients with uremic pruritus
6 g2 weeks—
Efficacy of novel activated bamboo charcoal in reducing uremic toxins and enhancing kidney function in chronic kidney disease patients: a pilot randomized controlled trial
2025 · ABC-treatment group · Adults with stage 3 chronic kidney disease; mean age 65.9 years, 83.3% male
12 g90 days12
The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers
2005 · Activated-charcoal pretreatment · Healthy volunteers and people with asthma; ages not reported, six males and six females in each group
560 mg1 day24
Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization
2002 · NEBC · 12 healthy volunteers
25 g1 day12
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects
2021 · DAV132 coadministered with warfarin or clonazepam · healthy volunteers; 18 in the warfarin substudy and 24 in the clonazepam substudy
7.5 g1 day42
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects
2021 · DAV132 administered 1 hour before warfarin or clonazepam · healthy volunteers; 18 in the warfarin substudy and 24 in the clonazepam substudy
7.5 g1 day42
Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration
2020 · Charcoal-block subjects · Healthy volunteers; age and sex not stated
9 g1 day36
Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects
2019 · SCA concomitant regimens (parts 1 and 2; timing varied) · Healthy Japanese men aged 20–45 years
6 g2 days34
Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose
2003 · SAC group · Healthy adult volunteers
75 g1 day22
Protection of the Human Gut Microbiome From Antibiotics
2018 · MXF + DAV132 · Healthy adult men and women older than 18 years
15.3 g7 days14
Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose
2010 · Experimental arm · 12 healthy male volunteers
50 g1 day12
Effect of anticholinergic drugs on the efficacy of activated charcoal
2004 · activated charcoal alone · 10 healthy volunteers
50 g1 day10
Effect of anticholinergic drugs on the efficacy of activated charcoal
2004 · activated charcoal with atropine · 10 healthy volunteers
50 g1 day10
Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal
1991 · 30 g activated charcoal 15 minutes after acetaminophen · Healthy adult men aged 21–39 years
30 g1 day10
Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal
1991 · 30 g activated charcoal 30 minutes after acetaminophen · Healthy adult men aged 21–39 years
30 g1 day10
Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal
1991 · 30 g activated charcoal 120 minutes after acetaminophen · Healthy adult men aged 21–39 years
30 g1 day10
Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram
1999 · activated charcoal alone · Nine healthy volunteers; age and sex not specified
25 g1 day9
Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage
2000 · activated charcoal · Nine healthy volunteers; age and sex not reported
25 g1 day9
Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil
2000 · activated charcoal · Nine healthy volunteers
25 g1 day9
Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs
2001 · 25 g activated charcoal as a suspension · 9 healthy subjects
25 g1 day9
Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs
2001 · 25 g activated charcoal as a suspension followed by whole-bowel irrigation with polyethylene glycol (PEG) electrolyte lavage solution · 9 healthy subjects
25 g1 day9
Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen
2009 · activated charcoal at 1 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone
50 g1 day9
Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen
2009 · activated charcoal at 2 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone
50 g1 day9
Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen
2009 · activated charcoal at 3 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone
50 g1 day9
Treatment of cholestasis of pregnancy with peroral activated charcoal. A preliminary study
1994 · Activated peroral charcoal · Women with cholestasis of pregnancy
150 g8 days9
Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers
1990 · activated charcoal suspension · Healthy volunteers; age and sex not specified.
5 g1 day8
Drug adsorption efficacy and palatability of a novel charcoal cookie formulation
2010 · charcoal cookies · Eight healthy adults, five men and three women, mean age 23.4 years
7.2 g1 day8
Drug adsorption efficacy and palatability of a novel charcoal cookie formulation
2010 · aqueous activated charcoal suspension · Eight healthy adults, five men and three women, mean age 23.4 years
7.2 g1 day8
Protection of the Human Gut Microbiome From Antibiotics
2018 · DAV132 alone · Healthy adult men and women older than 18 years
15.3 g7 days8
The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration
1996 · Second group · healthy volunteers
25 g1 day8
The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration
1996 · Third group · healthy volunteers
25 g1 day8
The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration
1996 · Fourth group · healthy volunteers
25 g1 day8
Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration
1997 · Activated charcoal administered immediately after amlodipine · Healthy volunteers
25 g1 day8
Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration
1997 · Activated charcoal administered 2 h after amlodipine · Healthy volunteers
25 g1 day8
Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration
1997 · Activated charcoal administered 6 h after amlodipine · Healthy volunteers
25 g1 day8
Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels
2012 · multiple-dose activated charcoal (MDAC) · Adults older than 18, all male, with serum phenytoin levels greater than 30 mg/L upon presentation; nonpregnant and able to tolerate activated charcoal by mouth
300 g—7
The effect of activated charcoal on the absorption and elimination of astemizole
1994 · multiple-dose activated charcoal group · Healthy volunteers; age and sex not reported
24 g8 days7
Acceleration of body clearance of diethylCarbamazine by oral activated charcoal
2000 · 7.5 g activated charcoal · Six healthy volunteers; age and sex not specified
7.5 g1 day6
Acceleration of body clearance of diethylCarbamazine by oral activated charcoal
2000 · 15 g activated charcoal · Six healthy volunteers; age and sex not specified
15 g1 day6
Prevention of chloroquine absorption by activated charcoal
1992 · Activated charcoal group · Healthy volunteers; age and sex not reported
25 g1 day6
Effect of activated charcoal on the absorption of amiodarone
1991 · Charcoal administered simultaneously with amiodarone · Healthy volunteers; age and sex not reported
25 g1 day6
Effect of activated charcoal on the absorption of amiodarone
1991 · Charcoal administered 1.5 hours after amiodarone · Healthy volunteers; age and sex not reported
25 g1 day6
The adsorption of salicylates by a milk chocolate-charcoal mixture
1991 · Milk chocolate-charcoal mixture · Six healthy adult volunteers; sex and age range not reported; no stated medical condition
10 g1 day6
The adsorption of salicylates by a milk chocolate-charcoal mixture
1991 · SuperChar Liquid · Six healthy adult volunteers; sex and age range not reported; no stated medical condition
10 g1 day6
The adsorption of salicylates by a milk chocolate-charcoal mixture
1991 · Actidose Aqua activated charcoal · Six healthy adult volunteers; sex and age range not reported; no stated medical condition
10 g1 day6
Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration
2020 · Pilot study: charcoal-based regimen · Six healthy subjects; age and sex not stated
9 g1 day6
Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal
1993 · ipecac-charcoal · Six healthy volunteer men
50 g1 day6
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study
2023 · Part IV, cohort 1: activated charcoal 60 g once daily · Healthy men aged 18–45 years of sub-Saharan origin
60 g7 days3
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study
2023 · Part IV, cohort 2: activated charcoal 20 g three times daily · Healthy men aged 18–45 years of sub-Saharan origin
60 g7 days3
Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers
2010 · 50 g activated charcoal (control) · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported
50 g1 day—
Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers
2010 · 25 g activated charcoal · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported
25 g1 day—
Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers
2010 · 5 g activated charcoal · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported
5 g1 day—
Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate
2010 · arm 2, receiving i.v. AS and oral AC simultaneously · Healthy adults aged 21–45 years, malaria-negative, not pregnant, and with haemoglobin >11 g/dl
100 g1 day—
Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate
2010 · arm 3, receiving i.v. AS and oral AC 1 h later · Healthy adults aged 21–45 years, malaria-negative, not pregnant, and with haemoglobin >11 g/dl
100 g1 day—
Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students
1990 · 40 mg frusemide and 8 g activated charcoal taken together · medical students; age and sex not reported
8 g1 day—
Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students
1990 · 40 mg frusemide and 8 g activated charcoal taken after different time intervals · medical students; age and sex not reported
8 g1 day—
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study
2023 · Part I cohorts receiving once-daily activated charcoal (except cohorts 1 and 9) · Healthy men aged 18–45 years of sub-Saharan origin
60 g7 days—
Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers
2017 · Healthy volunteers receiving activated charcoal · Healthy adult volunteers; age and sex not specified
20 g1 day12
Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil
1997 · Conventional verapamil with activated charcoal immediately afterwards · Healthy volunteers; age and sex not reported
25 g1 day9
Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil
1997 · Conventional verapamil with charcoal 2 h later · Healthy volunteers; age and sex not reported
25 g1 day9
Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil
1997 · Slow-release verapamil with activated charcoal immediately afterwards · Healthy volunteers; age and sex not reported
25 g1 day8
Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil
1997 · Slow-release verapamil with charcoal 2 h later · Healthy volunteers; age and sex not reported
25 g1 day8
Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil
1997 · Slow-release verapamil with charcoal 4 h later · Healthy volunteers; age and sex not reported
25 g1 day8
The comparative efficacy of various multiple-dose activated charcoal regimens
1992 · 12.5 gm every hour · Five healthy adult volunteers
12.5 g1 day5
The comparative efficacy of various multiple-dose activated charcoal regimens
1992 · 25 gm every 2 hours · Five healthy adult volunteers
12.5 g1 day5
The comparative efficacy of various multiple-dose activated charcoal regimens
1992 · 50 gm every 4 hours · Five healthy adult volunteers
12.5 g1 day5